Clinuvel Pharmaceuticals Ltd (CUV) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Based on the latest financial reports, Clinuvel Pharmaceuticals Ltd (CUV) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$12.52 Million ≈ $8.86 Million USD) by net assets (AU$249.02 Million ≈ $176.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Clinuvel Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Clinuvel Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Clinuvel Pharmaceuticals Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Clinuvel Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinuvel Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
VRG SA
WAR:VRG
0.016x
CHEERWIN GRP. -0000002
F:1RQ
N/A
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
-0.040x
NOCIL Limited
NSE:NOCIL
0.077x
Fujian Yongan Forestry Group Joint-Stock
SHE:000663
-0.019x
Stalprodukt SA
WAR:STP
0.028x
Aofu Environmental Technology Co Ltd
SHG:688021
0.023x
Yungshin Construction & Development Co Ltd
TWO:5508
-0.035x

Annual Cash Flow Conversion Efficiency for Clinuvel Pharmaceuticals Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Clinuvel Pharmaceuticals Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$240.81 Million
≈ $170.39 Million
AU$41.10 Million
≈ $29.08 Million
0.171x -6.50%
2024-06-30 AU$203.01 Million
≈ $143.64 Million
AU$37.05 Million
≈ $26.22 Million
0.183x -18.59%
2023-06-30 AU$164.63 Million
≈ $116.49 Million
AU$36.91 Million
≈ $26.12 Million
0.224x -29.40%
2022-06-30 AU$125.56 Million
≈ $88.84 Million
AU$39.87 Million
≈ $28.21 Million
0.318x +62.78%
2021-06-30 AU$98.74 Million
≈ $69.86 Million
AU$19.26 Million
≈ $13.63 Million
0.195x -0.91%
2020-06-30 AU$72.07 Million
≈ $50.99 Million
AU$14.19 Million
≈ $10.04 Million
0.197x -39.00%
2019-06-30 AU$57.18 Million
≈ $40.46 Million
AU$18.46 Million
≈ $13.06 Million
0.323x +8.80%
2018-06-30 AU$39.42 Million
≈ $27.89 Million
AU$11.69 Million
≈ $8.27 Million
0.297x -23.88%
2017-06-30 AU$25.44 Million
≈ $18.00 Million
AU$9.92 Million
≈ $7.02 Million
0.390x +238.00%
2016-06-30 AU$17.83 Million
≈ $12.62 Million
AU$-5.04 Million
≈ $-3.56 Million
-0.282x +30.14%
2015-06-30 AU$11.21 Million
≈ $7.93 Million
AU$-4.53 Million
≈ $-3.21 Million
-0.404x -29.70%
2014-06-30 AU$15.43 Million
≈ $10.92 Million
AU$-4.81 Million
≈ $-3.40 Million
-0.312x +37.41%
2013-06-30 AU$13.84 Million
≈ $9.79 Million
AU$-6.89 Million
≈ $-4.88 Million
-0.498x +32.24%
2012-06-30 AU$13.64 Million
≈ $9.65 Million
AU$-10.02 Million
≈ $-7.09 Million
-0.735x -27.11%
2011-06-30 AU$16.41 Million
≈ $11.61 Million
AU$-9.49 Million
≈ $-6.71 Million
-0.578x -29.67%
2010-06-30 AU$26.43 Million
≈ $18.70 Million
AU$-11.78 Million
≈ $-8.34 Million
-0.446x -50.38%
2009-06-30 AU$37.05 Million
≈ $26.22 Million
AU$-10.99 Million
≈ $-7.77 Million
-0.296x -113.93%
2008-06-30 AU$51.81 Million
≈ $36.66 Million
AU$-7.18 Million
≈ $-5.08 Million
-0.139x -10.81%
2007-06-30 AU$65.39 Million
≈ $46.27 Million
AU$-8.18 Million
≈ $-5.79 Million
-0.125x +84.66%
2006-06-30 AU$13.99 Million
≈ $9.90 Million
AU$-11.40 Million
≈ $-8.07 Million
-0.815x +34.28%
2005-06-30 AU$7.45 Million
≈ $5.27 Million
AU$-9.25 Million
≈ $-6.54 Million
-1.240x -82.98%
2004-06-30 AU$8.85 Million
≈ $6.27 Million
AU$-6.00 Million
≈ $-4.25 Million
-0.678x -180.66%
2002-06-30 AU$10.31 Million
≈ $7.29 Million
AU$-2.49 Million
≈ $-1.76 Million
-0.242x -531.42%
2001-06-30 AU$13.45 Million
≈ $9.52 Million
AU$-514.54K
≈ $-364.07K
-0.038x --

About Clinuvel Pharmaceuticals Ltd

AU:CUV Australia Biotechnology
Market Cap
$339.22 Million
AU$479.42 Million AUD
Market Cap Rank
#14478 Global
#381 in Australia
Share Price
AU$9.55
Change (1 day)
+3.24%
52-Week Range
AU$8.79 - AU$13.70
All Time High
AU$44.55
About

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with e… Read more